Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02619682Phase 2Completed
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Plasma Cell MyelomaTransplant-Related Carcinoma
PrincipalinvestigatorStart date: 2015-12-30
NCT01413100Phase 2Completed
Scleroderma Treatment With Autologous Transplant (STAT) Study
Systemic Scleroderma
PrincipalinvestigatorStart date: 2011-09-15
NCT00716066Phase 2Active Not Recruiting
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Autoimmune DiseaseAutoimmune Nervous System DisorderAutologous Transplant Autoimmune+16 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma
Similarity Score3%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma
Similarity Score3%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-Hodgkin

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-Hodgkin
Similarity Score3%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma
Similarity Score3%

He Huang, MD

First Affiliated Hospital of Zhejiang University

Related
15 trials

Shared therapeutic areas:

Multiple MyelomaNeuromyelitis Optica
Similarity Score3%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score1%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin
Similarity Score1%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin
Similarity Score1%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02619682Phase 2PrincipalInvestigator

Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell MyelomaTransplant-Related Carcinoma
Completed
NCT01413100Phase 2PrincipalInvestigator

Scleroderma Treatment With Autologous Transplant (STAT) Study

Systemic Scleroderma
Completed
NCT01097057Phase 2PrincipalInvestigator

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

Non-Hodgkin Lymphoma
Completed
NCT00716066Phase 2PrincipalInvestigator

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Autoimmune DiseaseAutoimmune Nervous System DisorderAutologous Transplant Autoimmune+16 more
Active Not Recruiting

All 4 trials loaded